About UsOrion BioScience is a biotechnology company developing two platforms to treat autoimmune diseases and autoimmune associated inflammation. Founded in 2012 as a spinout from the University of Kansas, and now located in Omaha, NE, Orion brings together a talented team, including decades of executive start-up experience in Silicon Valley in both private and public Biotech. The combination of ground-breaking technologies, a proven team, and a region ready to expedite preclinical efforts, uniquely positions Orion to reach value-inflection points rapidly and cost-effectively.
|
|
The Orion Approach
Orion BioScience Inc. is focused on developingour SAgA therapeutic modality to intercept, reverse, and ameliorate the devastating effects of autoimmune diseases. We have invented two disruptive technologies to provide both immediate relief and a long-term solution for 100M+ people.
|
Orion's Exclusivity
Orion’s intellectual property includes significant know-how, issued US patents, and a global patent estate covering the both of our technology platforms, both of which have been exclusively licensed from the University of Kansas for all fields and territories.
|